12th Annual Scientific Meeting
26th - 28th July 2021
Oxford University, Examination School
BOMSS welcomed Delegates and Industry to the 12th BOMSS Annual Scientific Meeting which took place in at the Oxford University, Examination School from the 27th – 28th July 2021.
The meeting kicked off with BOMSS holding a Training Day for Trainee Surgeons and Integrated Healthcare Professionals on Monday 26th July 2021. The training day covered four topical areas, Abdominal pain post bariatric surgery, When to say 'no' to bariatric surgery, The recovering bariatric unit and key lessons in Gastric Band Management.
The Annual Scientific Meeting programme took place on Tuesday 27th July and Wednesday 28th July with over 250 attendees arriving in Oxford. The programme covered all the important topics for the entire multidisciplinary team, with speaker from across the UK, Europe and USA.
BOMSS would like to thank all the delegates, speakers and industry for their contribution to the meeting.
Best Poster 2021 - Dr Husham Ahmed
Abstract title: Using the Ensuring Quality Information for Patients Tool to Assess Patient Information on Sleeve Gastrectomy Websites
Joint winner: BOMSS Surgical Research Presentation Prize - Chanpreet Arhi
Abstract title: Duration in a Tier 3 does not improve weight loss or progression to surgery
Joint winner: BOMSS Surgical Research Presentation Prize - Niall Dempster
Abstract title: Bariatric surgery restores dysregulated hepatic lipid metabolism and promotes regression across the spectrum of NAFLD
Novo Nordisk has provided sponsorship to BOMSS-CIO to contribute towards the running costs of this meeting, but has had no influence over the meeting arrangements (with the exception of the Novo Nordisk symposium on the meeting programme).
Novo Nordisk has provided sponsorship to the British Obesity & Metabolic Surgery Society – Charitable Incorporate Organisation (BOMSS-CIO) to contribute towards the running costs of the BOMSS-CIO’s Annual Scientific Meeting (ASM) 2021. Novo Nordisk has had no influence over the creation, development or content of the meeting and full control remains the responsibility of BOMSS-CIO (with the exception of the Novo Nordisk symposium session indicated on the meeting programme).